Image

Ultrasonographic Evaluation of Talar Cartilage Thickness in Patients With Spinal Cord Injury

Ultrasonographic Evaluation of Talar Cartilage Thickness in Patients With Spinal Cord Injury

Recruiting
18-60 years
All
Phase N/A

Powered by AI

Overview

Spinal cord injury patients often present with musculoskeletal comorbidities, including osteoarthritis. Early detection of cartilage damage is important for preventing osteoarthritis progression. This study aims to compare the talar cartilage thicknesses of spinal cord injury patients with healthy subjects. The secondary aim is to investigate a correlation between the talar cartilage thickness and disease-related parameters. The patient group is to be assessed for talar cartilage thickness (via ultrasound), functional status, spasticity, and ambulation levels.

Eligibility

Inclusion Criteria:

  • Aged between 18 to 60 years,
  • Cervical, thoracal or lumber level of spinal cord injury
  • AIS (American Spinal Injury Association Impairment Scale) Level A, B, C, or D
  • Assisted ambulation of any kind
  • Literacy
  • Giving oral and written consent to participate in the study

Exclusion Criteria:

  • Patients with sacral level injury
  • AIS E
  • MAS 4 level of spasticity
  • History of any lower extremity operation
  • History of fracture
  • Botulinum toxin injection in the last 6 months
  • Existing diagnosis of any rheumatologic or endocrine diseases

Study details
    Spinal Cord Injuries (SCI)
    Osteoarthritis (OA)

NCT07293949

Gaziosmanpasa Research and Education Hospital

1 February 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.